Shaanxi Kanghui Pharmaceutical Co., Ltd.
SHH: 603139.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Yanling Wang
- Employees
- 952
- Headquarters
- Xianyang, China
- IPO year
- 2017
- Market cap
- CN¥3.8B
- Website
- https://www.sxkh.com
Loading 603139…
Loading profile data…Frequently asked questions about 603139
What does Shaanxi Kanghui Pharmaceutical Co., Ltd. (603139.SS) do?
Shaanxi Kanghui Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. It offers gynecological, orthopedic, dermatology, diabetes, respiratory system, urinary system, cardiovascular and cerebrovascular, gastrointestinal, hepatobiliary, and other drugs in the form of tablets, ca...
Where does 603139.SS trade?
Shaanxi Kanghui Pharmaceutical Co., Ltd. (603139.SS) trades on the Shanghai Stock Exchange.
What sector is 603139.SS in?
Shaanxi Kanghui Pharmaceutical Co., Ltd. (603139.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Shaanxi Kanghui Pharmaceutical Co., Ltd.?
Yanling Wang is the chief executive officer of Shaanxi Kanghui Pharmaceutical Co., Ltd. (603139.SS).
Where is Shaanxi Kanghui Pharmaceutical Co., Ltd. headquartered?
Shaanxi Kanghui Pharmaceutical Co., Ltd. is headquartered in China.
Does 603139.SS pay a dividend?
Shaanxi Kanghui Pharmaceutical Co., Ltd. (603139.SS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 603139.SS go public?
Shaanxi Kanghui Pharmaceutical Co., Ltd. (603139.SS) completed its initial public offering in 2017.